Met
- Announced
- 30 Oct 2025
- Due
- 31 Dec 2025
A Evidence (SEC filing) ↗ Original promise ↗AI-confirmed · human review in progress
Ticker LLY. 38 dated commitments on record, none still open. History read from 2016, last updated 10 Oct 2026.
Separate measures of what ELI Lilly & Co said and what the public record showed, from 38 commitments. Every entry is listed below with its sources. How outcomes are decided
Kept Scores are not yet published
We are building the verified historical record first. Scores will be published once there is enough hand-checked history for them to mean something, and the methodology will be fixed and dated before the first score appears. This company has 2 commitments with a clear outcome in the last 3 years (the Kept Score window); the execution profile covers all years on record. How the score will work
90% of ELI Lilly & Co's commitments with a clear outcome were delivered by the original date: in line with the Health Care median of 90%, across 11 S&P 500 Health Care companies with enough outcomes to compare (rank 6 of 11).
Median across the S&P 500: 78%. A count of outcomes, not a Kept Score or a rating. See every S&P 100 company
Add it to your watchlist to see what it has coming due next to the other companies you follow. With KeptIndex Pro, get an email when a deadline is revised, comes due or has its outcome recorded.
Met
A Evidence (SEC filing) ↗ Original promise ↗AI-confirmed · human review in progress
Met
A Evidence (SEC filing) ↗ Original promise ↗AI-confirmed · human review in progress
No record found
Met
A Evidence (SEC filing) ↗ Original promise ↗AI-assessed · human review in progress
Met
A Evidence (SEC filing) ↗ Original promise ↗AI-confirmed · human review in progress
Met
A Evidence (SEC filing) ↗ Original promise ↗AI-confirmed · human review in progress
No record found
Met
A Evidence (SEC filing) ↗ Original promise ↗AI-confirmed · human review in progress
No record found
Met
A Evidence (SEC filing) ↗ Original promise ↗AI-assessed · human review in progress
No record found
Latedelivered Q2 2022
A Evidence (SEC filing) ↗ Original promise ↗AI-confirmed · human review in progress
Met
A Evidence (SEC filing) ↗ Original promise ↗AI-confirmed · human review in progress
Met
A Evidence (SEC filing) ↗ Original promise ↗AI-confirmed · human review in progress
Met
A Evidence (SEC filing) ↗ Original promise ↗AI-assessed · human review in progress
Met
A Evidence (SEC filing) ↗ Original promise ↗AI-confirmed · human review in progress
No record found
Withdrawn
A Evidence (SEC filing) ↗ Original promise ↗AI-confirmed · human review in progress
No record found
Met
A Evidence (SEC filing) ↗ Original promise ↗AI-confirmed · human review in progress
No record found
No record found
No record found
No record found
Met
A Evidence (SEC filing) ↗ Original promise ↗AI-confirmed · human review in progress
Met
A Evidence (SEC filing) ↗ Original promise ↗AI-confirmed · human review in progress
Met
A Evidence (SEC filing) ↗ Original promise ↗AI-confirmed · human review in progress
Met
A Evidence (SEC filing) ↗ Original promise ↗AI-confirmed · human review in progress
Met
A Evidence (SEC filing) ↗ Original promise ↗AI-confirmed · human review in progress
No record found
No record found
Met
A Evidence (SEC filing) ↗ Original promise ↗AI-assessed · human review in progress
No record found
No record found
No record found
No record found
No record found
No record found
Every commitment, outcome, evidence link and restatement as a report and spreadsheet, checked by a researcher against the SEC filings and emailed within one business day of payment.
This page is public and free. Claim it to get a reminder before each deadline ELI Lilly & Co announced, add your own sources to any entry, and receive a quarterly summary compared with your sector.
Does something on this page need correcting? ELI Lilly & Co and any reader can ask us to check an entry, with a link to a public source.
One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.
No advertising. We never sell or share your address.